

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.12434135 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.12434135 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.76499899 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.41616808 |
| 5 | DNA deamination (GO:0045006) | 4.64130920 |
| 6 | cellular response to zinc ion (GO:0071294) | 4.21397158 |
| 7 | response to peptidoglycan (GO:0032494) | 4.11834165 |
| 8 | viral transcription (GO:0019083) | 4.03012435 |
| 9 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.95013241 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90627983 |
| 11 | response to interferon-beta (GO:0035456) | 3.87165531 |
| 12 | translational termination (GO:0006415) | 3.82390016 |
| 13 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.77519004 |
| 14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.75942012 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 3.75110872 |
| 16 | platelet dense granule organization (GO:0060155) | 3.75041022 |
| 17 | negative regulation of phagocytosis (GO:0050765) | 3.65158594 |
| 18 | cotranslational protein targeting to membrane (GO:0006613) | 3.64473350 |
| 19 | protein targeting to ER (GO:0045047) | 3.63988308 |
| 20 | response to interferon-alpha (GO:0035455) | 3.61117750 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60762813 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58614365 |
| 23 | detection of bacterium (GO:0016045) | 3.57731791 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53265942 |
| 25 | detection of other organism (GO:0098543) | 3.50404363 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47352104 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.47352104 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47352104 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47352104 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47352104 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.47352104 |
| 32 | protein localization to endoplasmic reticulum (GO:0070972) | 3.46035577 |
| 33 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.45227482 |
| 34 | translational elongation (GO:0006414) | 3.44426356 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.43716303 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.34303281 |
| 37 | definitive hemopoiesis (GO:0060216) | 3.32907381 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.26090781 |
| 39 | regulation of B cell differentiation (GO:0045577) | 3.22980088 |
| 40 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.12956870 |
| 41 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.12956870 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.10329854 |
| 43 | response to type I interferon (GO:0034340) | 3.08350174 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.07410574 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.07410574 |
| 46 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05233910 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.03343271 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00353186 |
| 49 | neutrophil mediated immunity (GO:0002446) | 2.99904665 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 2.99124854 |
| 51 | defense response to protozoan (GO:0042832) | 2.98379944 |
| 52 | viral life cycle (GO:0019058) | 2.97865665 |
| 53 | megakaryocyte development (GO:0035855) | 2.96369573 |
| 54 | mature B cell differentiation involved in immune response (GO:0002313) | 2.95769666 |
| 55 | positive regulation of lamellipodium assembly (GO:0010592) | 2.92431656 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 2.92150921 |
| 57 | cellular extravasation (GO:0045123) | 2.92115594 |
| 58 | respiratory burst (GO:0045730) | 2.91807015 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85442973 |
| 60 | response to host immune response (GO:0052572) | 2.85442973 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85055140 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 2.84588200 |
| 63 | pentose-phosphate shunt (GO:0006098) | 2.84276842 |
| 64 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.83010511 |
| 65 | angiogenesis involved in wound healing (GO:0060055) | 2.81613573 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 2.81562486 |
| 67 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81550243 |
| 68 | response to protozoan (GO:0001562) | 2.80848400 |
| 69 | ribosomal small subunit biogenesis (GO:0042274) | 2.79795560 |
| 70 | macrophage activation involved in immune response (GO:0002281) | 2.79463122 |
| 71 | detection of biotic stimulus (GO:0009595) | 2.77940693 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.77899782 |
| 73 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.74203267 |
| 74 | pinocytosis (GO:0006907) | 2.73796567 |
| 75 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.73771140 |
| 76 | purine-containing compound salvage (GO:0043101) | 2.71813762 |
| 77 | regulation of natural killer cell differentiation (GO:0032823) | 2.71337108 |
| 78 | T cell homeostasis (GO:0043029) | 2.71080449 |
| 79 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68568142 |
| 80 | endosome to melanosome transport (GO:0035646) | 2.68294034 |
| 81 | endosome to pigment granule transport (GO:0043485) | 2.68294034 |
| 82 | regulation of B cell apoptotic process (GO:0002902) | 2.67856586 |
| 83 | actin nucleation (GO:0045010) | 2.66830829 |
| 84 | negative regulation of granulocyte differentiation (GO:0030853) | 2.66725682 |
| 85 | DNA strand elongation (GO:0022616) | 2.64474272 |
| 86 | negative regulation of interleukin-12 production (GO:0032695) | 2.64368342 |
| 87 | positive regulation of lamellipodium organization (GO:1902745) | 2.64276093 |
| 88 | cellular protein complex disassembly (GO:0043624) | 2.63833504 |
| 89 | lymph node development (GO:0048535) | 2.62375180 |
| 90 | necroptotic process (GO:0070266) | 2.62048611 |
| 91 | xenobiotic catabolic process (GO:0042178) | 2.62045289 |
| 92 | negative regulation of innate immune response (GO:0045824) | 2.61463251 |
| 93 | myeloid dendritic cell activation (GO:0001773) | 2.60720592 |
| 94 | secretory granule organization (GO:0033363) | 2.60634937 |
| 95 | hyaluronan catabolic process (GO:0030214) | 2.60075240 |
| 96 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.59675954 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.59618158 |
| 98 | response to host (GO:0075136) | 2.59618158 |
| 99 | response to host defenses (GO:0052200) | 2.59618158 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59405600 |
| 101 | toxin transport (GO:1901998) | 2.59282317 |
| 102 | B cell mediated immunity (GO:0019724) | 2.58318684 |
| 103 | translational initiation (GO:0006413) | 2.58266445 |
| 104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57066863 |
| 105 | myeloid leukocyte mediated immunity (GO:0002444) | 2.55901906 |
| 106 | respiratory chain complex IV assembly (GO:0008535) | 2.55712274 |
| 107 | regulation of macrophage cytokine production (GO:0010935) | 2.55666866 |
| 108 | mature B cell differentiation (GO:0002335) | 2.55610726 |
| 109 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.54256968 |
| 110 | myeloid cell activation involved in immune response (GO:0002275) | 2.53555193 |
| 111 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.53511220 |
| 112 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.52660278 |
| 113 | valine metabolic process (GO:0006573) | 2.52530146 |
| 114 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.52141440 |
| 115 | endothelium development (GO:0003158) | 2.51940779 |
| 116 | regulation of necroptotic process (GO:0060544) | 2.51682180 |
| 117 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.51583264 |
| 118 | maturation of SSU-rRNA (GO:0030490) | 2.50183464 |
| 119 | execution phase of apoptosis (GO:0097194) | 2.50113555 |
| 120 | regulation of mast cell activation (GO:0033003) | 2.50044754 |
| 121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.48920990 |
| 122 | protein carboxylation (GO:0018214) | 2.48920990 |
| 123 | NADPH regeneration (GO:0006740) | 2.47956724 |
| 124 | negative regulation of bone mineralization (GO:0030502) | 2.47825129 |
| 125 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47793939 |
| 126 | negative regulation of cell killing (GO:0031342) | 2.47793939 |
| 127 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47129046 |
| 128 | phagocytosis, engulfment (GO:0006911) | 2.46590895 |
| 129 | defense response to fungus (GO:0050832) | 2.46492788 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.45767393 |
| 131 | neutrophil activation (GO:0042119) | 2.44787739 |
| 132 | amino sugar catabolic process (GO:0046348) | 2.44717102 |
| 133 | protein targeting to membrane (GO:0006612) | 2.44397871 |
| 134 | tricarboxylic acid metabolic process (GO:0072350) | 2.44358133 |
| 135 | regulation of superoxide anion generation (GO:0032928) | 2.43451287 |
| 136 | cellular response to interferon-beta (GO:0035458) | 2.42665659 |
| 137 | reactive oxygen species biosynthetic process (GO:1903409) | 2.41081694 |
| 138 | signal peptide processing (GO:0006465) | 2.41073877 |
| 139 | macrophage differentiation (GO:0030225) | 2.39520594 |
| 140 | Golgi transport vesicle coating (GO:0048200) | 2.38330471 |
| 141 | COPI coating of Golgi vesicle (GO:0048205) | 2.38330471 |
| 142 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.38300527 |
| 143 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.38297968 |
| 144 | sequestering of metal ion (GO:0051238) | 2.38140492 |
| 145 | barbed-end actin filament capping (GO:0051016) | 2.37859298 |
| 146 | complement activation, alternative pathway (GO:0006957) | 2.36888184 |
| 147 | purine nucleotide salvage (GO:0032261) | 2.36342688 |
| 148 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.36274452 |
| 149 | positive regulation of chemokine secretion (GO:0090197) | 2.35827107 |
| 150 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.35763842 |
| 151 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.35716532 |
| 152 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.35716532 |
| 153 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.35525193 |
| 154 | microglial cell activation (GO:0001774) | 2.35008549 |
| 155 | response to muramyl dipeptide (GO:0032495) | 2.33983990 |
| 156 | positive regulation of granulocyte differentiation (GO:0030854) | 2.33523346 |
| 157 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.32668393 |
| 158 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.30752123 |
| 159 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.30578871 |
| 160 | L-phenylalanine catabolic process (GO:0006559) | 2.30399088 |
| 161 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.30399088 |
| 162 | regulation of granulocyte differentiation (GO:0030852) | 2.28417843 |
| 163 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.28100935 |
| 164 | regulation of phagocytosis (GO:0050764) | 2.27325887 |
| 165 | leukocyte degranulation (GO:0043299) | 2.26867156 |
| 166 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.26585642 |
| 167 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.25125833 |
| 168 | granulocyte activation (GO:0036230) | 2.24261288 |
| 169 | negative regulation of interleukin-6 production (GO:0032715) | 2.23642629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.95696711 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.85182977 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.26981128 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.09833108 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.08896700 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.01910307 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.83063025 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.77633935 |
| 9 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.69740909 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69479145 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61540050 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.60892388 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53898113 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45170635 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.44213978 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40810885 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39036813 |
| 18 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35033257 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32415913 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.30886619 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16431222 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14137341 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.09935494 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.09869766 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06692909 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05029455 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03395228 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97405869 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.96590795 |
| 30 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94328112 |
| 31 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89476481 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89267045 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84397819 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83486872 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.83241801 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81578534 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81001940 |
| 38 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.80496341 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78924416 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78923848 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78649427 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78036817 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75893624 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70225229 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67606550 |
| 46 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.65537380 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.65449834 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64849046 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64588258 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.64264095 |
| 51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.61775505 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.59587866 |
| 53 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57348980 |
| 54 | * MYB_26560356_Chip-Seq_TH1_Human | 1.56768054 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54149981 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52407637 |
| 57 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.52295341 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51084701 |
| 59 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.51078438 |
| 60 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49774192 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49242982 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49094972 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45320574 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44262934 |
| 65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43576880 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41991369 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41865858 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40933948 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39863152 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39424455 |
| 71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38876858 |
| 72 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37570516 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34945081 |
| 74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34710511 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34124682 |
| 76 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33911999 |
| 77 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.33753860 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33382428 |
| 79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.30310431 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30042683 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29550067 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28254123 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28060589 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26187279 |
| 85 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25420730 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24996693 |
| 87 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24785287 |
| 88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24199456 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24098534 |
| 90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23840792 |
| 91 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23417731 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.22533354 |
| 93 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.22148850 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.21432695 |
| 95 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.21096148 |
| 96 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19979639 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19467132 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19187086 |
| 99 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18730673 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18467628 |
| 101 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.16207975 |
| 102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14249853 |
| 103 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.13738137 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13455126 |
| 105 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.12066538 |
| 106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11628817 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11450973 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11408314 |
| 109 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10494570 |
| 110 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10256371 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10154419 |
| 112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09165368 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 1.08108897 |
| 114 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07831847 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07053832 |
| 116 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.06260445 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05039594 |
| 118 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04899235 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04366727 |
| 120 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.04257709 |
| 121 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04153256 |
| 122 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03990035 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03709233 |
| 124 | * P300_27268052_Chip-Seq_Bcells_Human | 1.03367346 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03227299 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03195163 |
| 127 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02935626 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02730016 |
| 129 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02252667 |
| 130 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01405279 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00911649 |
| 132 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00316591 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00221211 |
| 134 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00078366 |
| 135 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99784517 |
| 136 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99480687 |
| 137 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98868351 |
| 138 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98096103 |
| 139 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.97471040 |
| 140 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97009496 |
| 141 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96932319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.56654091 |
| 2 | MP0002396_abnormal_hematopoietic_system | 2.96015283 |
| 3 | MP0005397_hematopoietic_system_phenotyp | 2.79423923 |
| 4 | MP0001545_abnormal_hematopoietic_system | 2.79423923 |
| 5 | MP0003436_decreased_susceptibility_to | 2.77858546 |
| 6 | MP0000685_abnormal_immune_system | 2.73992523 |
| 7 | MP0003724_increased_susceptibility_to | 2.66707199 |
| 8 | MP0009785_altered_susceptibility_to | 2.66385067 |
| 9 | MP0002132_abnormal_respiratory_system | 2.55021622 |
| 10 | MP0005025_abnormal_response_to | 2.41709395 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.34075704 |
| 12 | MP0002419_abnormal_innate_immunity | 2.30201423 |
| 13 | MP0001800_abnormal_humoral_immune | 2.25458733 |
| 14 | MP0005671_abnormal_response_to | 2.24430538 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.24061465 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.19223655 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.18766303 |
| 18 | MP0003303_peritoneal_inflammation | 2.09234306 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.07036666 |
| 20 | MP0002723_abnormal_immune_serum | 2.06900187 |
| 21 | MP0001853_heart_inflammation | 2.06854234 |
| 22 | MP0001790_abnormal_immune_system | 2.05808749 |
| 23 | MP0005387_immune_system_phenotype | 2.05808749 |
| 24 | MP0001819_abnormal_immune_cell | 2.04639815 |
| 25 | MP0009278_abnormal_bone_marrow | 2.03362830 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 2.01585990 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.96421382 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.95138397 |
| 29 | MP0002398_abnormal_bone_marrow | 1.89640559 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.84652010 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.83050088 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.82334158 |
| 33 | MP0000716_abnormal_immune_system | 1.76369007 |
| 34 | MP0001873_stomach_inflammation | 1.72638859 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.71827723 |
| 36 | MP0002405_respiratory_system_inflammati | 1.71637132 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.71577713 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.68557534 |
| 39 | MP0002429_abnormal_blood_cell | 1.59835580 |
| 40 | MP0000858_altered_metastatic_potential | 1.58773018 |
| 41 | MP0002722_abnormal_immune_system | 1.56711274 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.55484089 |
| 43 | MP0006054_spinal_hemorrhage | 1.53661331 |
| 44 | MP0009840_abnormal_foam_cell | 1.52138137 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.51796427 |
| 46 | MP0008004_abnormal_stomach_pH | 1.49625065 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.47646659 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.47506246 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.47406032 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.46620549 |
| 51 | MP0008469_abnormal_protein_level | 1.46510181 |
| 52 | MP0000343_altered_response_to | 1.41225489 |
| 53 | MP0000490_abnormal_crypts_of | 1.37653094 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.33963744 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.33895943 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.33379513 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.33128998 |
| 58 | MP0003186_abnormal_redox_activity | 1.33047556 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.26722678 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.24098179 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.23383577 |
| 62 | MP0003195_calcinosis | 1.22580438 |
| 63 | MP0005365_abnormal_bile_salt | 1.21558782 |
| 64 | MP0006082_CNS_inflammation | 1.21431445 |
| 65 | MP0008260_abnormal_autophagy | 1.20795001 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.18594598 |
| 67 | MP0002006_tumorigenesis | 1.18432450 |
| 68 | MP0002933_joint_inflammation | 1.16073952 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.15509439 |
| 70 | MP0009764_decreased_sensitivity_to | 1.14881739 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 1.10170395 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.09957448 |
| 73 | MP0009379_abnormal_foot_pigmentation | 1.09676726 |
| 74 | MP0003866_abnormal_defecation | 1.05654791 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.04720466 |
| 76 | MP0009763_increased_sensitivity_to | 1.04460018 |
| 77 | MP0003828_pulmonary_edema | 1.04388843 |
| 78 | MP0004947_skin_inflammation | 1.03873051 |
| 79 | MP0005390_skeleton_phenotype | 1.03758776 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.03284221 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.02665426 |
| 82 | MP0001879_abnormal_lymphatic_vessel | 1.01327160 |
| 83 | MP0001851_eye_inflammation | 1.00519251 |
| 84 | MP0003806_abnormal_nucleotide_metabolis | 0.98725034 |
| 85 | MP0000681_abnormal_thyroid_gland | 0.98634329 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.97573391 |
| 87 | MP0005164_abnormal_response_to | 0.97565145 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.97501586 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.97461430 |
| 90 | MP0001764_abnormal_homeostasis | 0.97098350 |
| 91 | MP0003075_altered_response_to | 0.95257262 |
| 92 | MP0005165_increased_susceptibility_to | 0.95172293 |
| 93 | MP0000598_abnormal_liver_morphology | 0.94508679 |
| 94 | MP0004883_abnormal_blood_vessel | 0.93452250 |
| 95 | MP0005410_abnormal_fertilization | 0.92364173 |
| 96 | MP0005083_abnormal_biliary_tract | 0.90717912 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.90658428 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.90265866 |
| 99 | MP0000609_abnormal_liver_physiology | 0.89848300 |
| 100 | MP0005166_decreased_susceptibility_to | 0.89539697 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89324600 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.86244370 |
| 103 | MP0009643_abnormal_urine_homeostasis | 0.85831009 |
| 104 | MP0008007_abnormal_cellular_replicative | 0.85368939 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.84536664 |
| 106 | MP0005310_abnormal_salivary_gland | 0.83663615 |
| 107 | MP0005367_renal/urinary_system_phenotyp | 0.83651027 |
| 108 | MP0000516_abnormal_urinary_system | 0.83651027 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83212883 |
| 110 | MP0004147_increased_porphyrin_level | 0.83019577 |
| 111 | MP0001661_extended_life_span | 0.82879017 |
| 112 | MP0000604_amyloidosis | 0.82877382 |
| 113 | MP0005085_abnormal_gallbladder_physiolo | 0.80904533 |
| 114 | MP0002095_abnormal_skin_pigmentation | 0.80712703 |
| 115 | MP0005332_abnormal_amino_acid | 0.80653290 |
| 116 | MP0001663_abnormal_digestive_system | 0.79908220 |
| 117 | MP0003252_abnormal_bile_duct | 0.79886328 |
| 118 | MP0000249_abnormal_blood_vessel | 0.79541790 |
| 119 | MP0001756_abnormal_urination | 0.78799295 |
| 120 | MP0001348_abnormal_lacrimal_gland | 0.78610376 |
| 121 | MP0004510_myositis | 0.78352004 |
| 122 | MP0002928_abnormal_bile_duct | 0.76882178 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.76867671 |
| 124 | MP0003279_aneurysm | 0.76571618 |
| 125 | MP0003795_abnormal_bone_structure | 0.75559150 |
| 126 | MP0010352_gastrointestinal_tract_polyps | 0.72289723 |
| 127 | MP0005360_urolithiasis | 0.68301581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 5.17592435 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.44286486 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.44286486 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.44286486 |
| 5 | Chronic otitis media (HP:0000389) | 4.30009655 |
| 6 | Abnormality of the nasal mucosa (HP:0000433) | 3.91581059 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85011016 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.77735474 |
| 9 | IgM deficiency (HP:0002850) | 3.76681519 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.70187794 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.66287354 |
| 12 | Spontaneous hematomas (HP:0007420) | 3.52336377 |
| 13 | Nasal polyposis (HP:0100582) | 3.45967243 |
| 14 | Petechiae (HP:0000967) | 3.36398310 |
| 15 | Reduced antithrombin III activity (HP:0001976) | 3.34743746 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.28010523 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.27932574 |
| 18 | Type I transferrin isoform profile (HP:0003642) | 3.09834373 |
| 19 | Myositis (HP:0100614) | 3.04955913 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.04685304 |
| 21 | Orchitis (HP:0100796) | 3.04454796 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 3.01802120 |
| 23 | Abnormal glycosylation (HP:0012345) | 3.01802120 |
| 24 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.01802120 |
| 25 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.01802120 |
| 26 | Aplastic anemia (HP:0001915) | 2.99704777 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.99692942 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97303092 |
| 29 | Generalized aminoaciduria (HP:0002909) | 2.86453863 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.82829987 |
| 31 | Epistaxis (HP:0000421) | 2.80972870 |
| 32 | Abnormal platelet function (HP:0011869) | 2.80431475 |
| 33 | Impaired platelet aggregation (HP:0003540) | 2.80431475 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 2.80280735 |
| 35 | Recurrent bronchitis (HP:0002837) | 2.79318356 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.74986796 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.71532835 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71532835 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.66718540 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.66167767 |
| 41 | Cellulitis (HP:0100658) | 2.65731511 |
| 42 | Stomatitis (HP:0010280) | 2.62602471 |
| 43 | Recurrent skin infections (HP:0001581) | 2.61281090 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.61007814 |
| 45 | Loss of speech (HP:0002371) | 2.59111666 |
| 46 | Complement deficiency (HP:0004431) | 2.58873381 |
| 47 | Reticulocytopenia (HP:0001896) | 2.56296595 |
| 48 | Poor head control (HP:0002421) | 2.54654353 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.52896536 |
| 50 | Recurrent viral infections (HP:0004429) | 2.52266148 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.51443944 |
| 52 | Peritonitis (HP:0002586) | 2.48645073 |
| 53 | Meningitis (HP:0001287) | 2.47727272 |
| 54 | Cervical subluxation (HP:0003308) | 2.46807664 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.46035825 |
| 56 | Pulmonary embolism (HP:0002204) | 2.44889111 |
| 57 | Amyloidosis (HP:0011034) | 2.43556722 |
| 58 | Abnormality of complement system (HP:0005339) | 2.42043140 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41616400 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41616400 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41616400 |
| 62 | Optic neuritis (HP:0100653) | 2.41059467 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.41059467 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.39085804 |
| 65 | Microcytic anemia (HP:0001935) | 2.37074186 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.36320184 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.35278784 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33493812 |
| 69 | Obstructive lung disease (HP:0006536) | 2.33493812 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.32658153 |
| 71 | Chronic sinusitis (HP:0011109) | 2.32442863 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32373683 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32373683 |
| 74 | Episodic fever (HP:0001954) | 2.31024050 |
| 75 | Prolonged neonatal jaundice (HP:0006579) | 2.30955467 |
| 76 | Hypoglycemic coma (HP:0001325) | 2.29517393 |
| 77 | Purpura (HP:0000979) | 2.29069849 |
| 78 | Arterial thrombosis (HP:0004420) | 2.28491726 |
| 79 | Colitis (HP:0002583) | 2.26998505 |
| 80 | Hematochezia (HP:0002573) | 2.26233904 |
| 81 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.22830903 |
| 82 | Microretrognathia (HP:0000308) | 2.21684078 |
| 83 | Gingival bleeding (HP:0000225) | 2.21532977 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.18794729 |
| 85 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.18552903 |
| 86 | Inflammation of the large intestine (HP:0002037) | 2.16426693 |
| 87 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.14770282 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.14411952 |
| 89 | Granulocytopenia (HP:0001913) | 2.13425881 |
| 90 | Hypochromic anemia (HP:0001931) | 2.13043628 |
| 91 | Myocardial infarction (HP:0001658) | 2.12501612 |
| 92 | Abnormality of T cells (HP:0002843) | 2.10824075 |
| 93 | Deep venous thrombosis (HP:0002625) | 2.10700635 |
| 94 | Exertional dyspnea (HP:0002875) | 2.10418803 |
| 95 | Increased muscle lipid content (HP:0009058) | 2.09389489 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08776441 |
| 97 | Hepatic necrosis (HP:0002605) | 2.07940641 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.06241165 |
| 99 | Gastrointestinal infarctions (HP:0005244) | 2.05506431 |
| 100 | Polycythemia (HP:0001901) | 2.04758462 |
| 101 | Ovoid vertebral bodies (HP:0003300) | 2.04700855 |
| 102 | Spondylolisthesis (HP:0003302) | 2.04211354 |
| 103 | Hemoptysis (HP:0002105) | 2.03772048 |
| 104 | Vertebral compression fractures (HP:0002953) | 2.03669012 |
| 105 | Polygenic inheritance (HP:0010982) | 2.02947252 |
| 106 | Gastrointestinal stroma tumor (HP:0100723) | 2.02107222 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01768699 |
| 108 | Fatigue (HP:0012378) | 2.01621292 |
| 109 | Protrusio acetabuli (HP:0003179) | 2.00178714 |
| 110 | Chest pain (HP:0100749) | 2.00135765 |
| 111 | Thrombophlebitis (HP:0004418) | 1.99181180 |
| 112 | Periodontitis (HP:0000704) | 1.98283729 |
| 113 | Vasculitis (HP:0002633) | 1.97673357 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97598297 |
| 115 | Rectal prolapse (HP:0002035) | 1.97527903 |
| 116 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97369227 |
| 117 | Lymphopenia (HP:0001888) | 1.97223855 |
| 118 | Joint stiffness (HP:0001387) | 1.97169786 |
| 119 | Acute hepatic failure (HP:0006554) | 1.96672781 |
| 120 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.96396456 |
| 121 | Thoracic kyphosis (HP:0002942) | 1.95711172 |
| 122 | Urticaria (HP:0001025) | 1.95544167 |
| 123 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93752686 |
| 124 | Hypertensive crisis (HP:0100735) | 1.92894468 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 1.92853692 |
| 126 | Glomerulonephritis (HP:0000099) | 1.92149551 |
| 127 | Panhypogammaglobulinemia (HP:0003139) | 1.91930409 |
| 128 | Encephalitis (HP:0002383) | 1.91427256 |
| 129 | Hypergammaglobulinemia (HP:0010702) | 1.91227602 |
| 130 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90970373 |
| 131 | Gingivitis (HP:0000230) | 1.90180722 |
| 132 | Menorrhagia (HP:0000132) | 1.89646683 |
| 133 | Abnormality of the common coagulation pathway (HP:0010990) | 1.89204740 |
| 134 | Osteomyelitis (HP:0002754) | 1.89087830 |
| 135 | Agnosia (HP:0010524) | 1.87896738 |
| 136 | Bruising susceptibility (HP:0000978) | 1.87309482 |
| 137 | Basal ganglia calcification (HP:0002135) | 1.87050902 |
| 138 | Increased serum ferritin (HP:0003281) | 1.86895290 |
| 139 | Bronchitis (HP:0012387) | 1.85955655 |
| 140 | Increased IgE level (HP:0003212) | 1.84270988 |
| 141 | Anorexia (HP:0002039) | 1.83950910 |
| 142 | Amaurosis fugax (HP:0100576) | 1.83890422 |
| 143 | Restrictive lung disease (HP:0002091) | 1.83607795 |
| 144 | Joint hemorrhage (HP:0005261) | 1.83332707 |
| 145 | Hypoplasia of the thymus (HP:0000778) | 1.83304060 |
| 146 | Abnormality of the lumbar spine (HP:0100712) | 1.82716618 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.82509567 |
| 148 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82244457 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.80501358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FLT3 | 3.07776080 |
| 2 | ERN1 | 2.96405294 |
| 3 | KIT | 2.77271409 |
| 4 | MAP4K1 | 2.65832697 |
| 5 | NME2 | 2.57148215 |
| 6 | BTK | 2.33276738 |
| 7 | MAP3K3 | 2.29082911 |
| 8 | TAOK3 | 2.26032979 |
| 9 | TEC | 2.24852123 |
| 10 | BCKDK | 2.21027013 |
| 11 | TGFBR2 | 2.19461412 |
| 12 | PIM2 | 2.17818755 |
| 13 | SCYL2 | 2.15413020 |
| 14 | EEF2K | 2.12872039 |
| 15 | IRAK4 | 2.02298835 |
| 16 | IRAK3 | 1.99151236 |
| 17 | BLK | 1.98365421 |
| 18 | TBK1 | 1.97186379 |
| 19 | TNK2 | 1.95280112 |
| 20 | MAP2K3 | 1.95215055 |
| 21 | ZAP70 | 1.94721518 |
| 22 | KDR | 1.91124748 |
| 23 | JAK3 | 1.88750993 |
| 24 | TYK2 | 1.71258712 |
| 25 | TESK2 | 1.64018912 |
| 26 | TGFBR1 | 1.60459714 |
| 27 | PINK1 | 1.59656991 |
| 28 | STK16 | 1.54647404 |
| 29 | RPS6KA4 | 1.54532715 |
| 30 | LRRK2 | 1.51940956 |
| 31 | CSF1R | 1.51691800 |
| 32 | SYK | 1.37268429 |
| 33 | TIE1 | 1.36224571 |
| 34 | MATK | 1.34235461 |
| 35 | TRIB3 | 1.32935978 |
| 36 | ARAF | 1.32146135 |
| 37 | PASK | 1.31418372 |
| 38 | SIK3 | 1.30696831 |
| 39 | VRK1 | 1.29053881 |
| 40 | PRKD2 | 1.25556088 |
| 41 | RIPK4 | 1.24509043 |
| 42 | PKN2 | 1.23469493 |
| 43 | WEE1 | 1.22979376 |
| 44 | EIF2AK3 | 1.16666075 |
| 45 | IKBKE | 1.15944003 |
| 46 | MAP3K1 | 1.15235976 |
| 47 | CDK8 | 1.14362193 |
| 48 | STK10 | 1.14146291 |
| 49 | SIK1 | 1.10108110 |
| 50 | MAP3K10 | 1.08087849 |
| 51 | MAP3K14 | 1.07215091 |
| 52 | FES | 1.04586193 |
| 53 | IKBKB | 1.03470274 |
| 54 | PRPF4B | 1.00439506 |
| 55 | CDK19 | 0.98463917 |
| 56 | LYN | 0.96622722 |
| 57 | ACVR1B | 0.92924963 |
| 58 | LCK | 0.87958232 |
| 59 | EPHB1 | 0.87651965 |
| 60 | PIM1 | 0.85888824 |
| 61 | ITK | 0.83728219 |
| 62 | MAP3K7 | 0.83022312 |
| 63 | DDR2 | 0.82022317 |
| 64 | PRKCQ | 0.81469998 |
| 65 | RPS6KA6 | 0.79318791 |
| 66 | NLK | 0.78949768 |
| 67 | RPS6KB2 | 0.78356129 |
| 68 | FGFR4 | 0.78073320 |
| 69 | MAPKAPK3 | 0.76606585 |
| 70 | MAP2K6 | 0.76577885 |
| 71 | TNIK | 0.76340864 |
| 72 | HCK | 0.76264137 |
| 73 | PDPK1 | 0.76218827 |
| 74 | MAP3K13 | 0.76069156 |
| 75 | MAPK11 | 0.75503752 |
| 76 | GRK6 | 0.74299573 |
| 77 | TAOK2 | 0.73533266 |
| 78 | CSK | 0.73492043 |
| 79 | HIPK2 | 0.73010535 |
| 80 | TAOK1 | 0.72892549 |
| 81 | MAPKAPK5 | 0.69734891 |
| 82 | MAPK7 | 0.68297162 |
| 83 | DYRK3 | 0.68139023 |
| 84 | MYLK | 0.65792313 |
| 85 | IRAK1 | 0.65729379 |
| 86 | SMG1 | 0.65302547 |
| 87 | DAPK3 | 0.65221844 |
| 88 | MOS | 0.64967499 |
| 89 | CDK4 | 0.64696976 |
| 90 | PDK1 | 0.64437133 |
| 91 | ABL2 | 0.62939792 |
| 92 | TRPM7 | 0.62850076 |
| 93 | MAP3K11 | 0.61934155 |
| 94 | RPS6KC1 | 0.61934069 |
| 95 | RPS6KL1 | 0.61934069 |
| 96 | MAPK15 | 0.61509836 |
| 97 | PRKG2 | 0.61078800 |
| 98 | BRSK2 | 0.59415218 |
| 99 | ADRBK1 | 0.58394054 |
| 100 | FGFR3 | 0.56961756 |
| 101 | JAK1 | 0.55957557 |
| 102 | PTK2B | 0.55693570 |
| 103 | DAPK1 | 0.54889099 |
| 104 | JAK2 | 0.54782289 |
| 105 | MAPK12 | 0.51280181 |
| 106 | MAPK4 | 0.50808581 |
| 107 | RET | 0.50717823 |
| 108 | DYRK1B | 0.50570861 |
| 109 | TESK1 | 0.49885471 |
| 110 | ADRBK2 | 0.49446698 |
| 111 | PIK3CG | 0.49382609 |
| 112 | RIPK1 | 0.48999802 |
| 113 | MAPKAPK2 | 0.48208944 |
| 114 | GRK5 | 0.48130271 |
| 115 | SIK2 | 0.47317511 |
| 116 | CLK1 | 0.46829923 |
| 117 | RAF1 | 0.45137036 |
| 118 | FGR | 0.44734887 |
| 119 | EPHA3 | 0.44428615 |
| 120 | CDC42BPA | 0.43702594 |
| 121 | RPS6KA2 | 0.43690769 |
| 122 | PTK6 | 0.43541103 |
| 123 | MAP4K2 | 0.42989635 |
| 124 | PAK4 | 0.42837958 |
| 125 | ILK | 0.42123617 |
| 126 | CHUK | 0.41575264 |
| 127 | MAP3K8 | 0.41228866 |
| 128 | CAMKK2 | 0.40626673 |
| 129 | PRKCD | 0.40398711 |
| 130 | CDK9 | 0.40010400 |
| 131 | PRKD1 | 0.39786619 |
| 132 | MAP3K5 | 0.39326925 |
| 133 | TLK1 | 0.39313896 |
| 134 | MARK3 | 0.38822173 |
| 135 | GRK7 | 0.37935345 |
| 136 | MARK2 | 0.37786806 |
| 137 | FRK | 0.36543652 |
| 138 | MUSK | 0.36450234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.65026054 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.41933433 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.51760044 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.47311165 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43978865 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.34476263 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.23737056 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17460568 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14662288 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.04642713 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.02483593 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.00535017 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98728450 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.97004510 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96144210 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94725210 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.85268451 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79316900 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74693342 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64181518 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.62207321 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.59296332 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44770789 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.40938619 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40804849 |
| 26 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.36717234 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33865616 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.32670659 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32424588 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.32060714 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31878630 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31487867 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.31324722 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.31239724 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.30135306 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29895128 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29677747 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.28773647 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24646655 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24311714 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22366636 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.20741346 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20400992 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18378261 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17496258 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17388521 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15272951 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12482183 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11906812 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10892124 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10655578 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10009088 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09827501 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09467275 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.09425331 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06685237 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.02759374 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01136158 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00300014 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99230500 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98888521 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97176060 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95839248 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.93412882 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.91695812 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90355919 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 0.89717353 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89155386 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88301143 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87375970 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87230632 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.86222761 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85797784 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85620286 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85330442 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.85295315 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.84375384 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.81866491 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80962085 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80690292 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80539504 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80232795 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79457051 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79307912 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78770737 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75952396 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.75320916 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75110536 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72755744 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71801585 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71565208 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.71363459 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.71122182 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71096759 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69092547 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67508945 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67365632 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67207369 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66065748 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64558976 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63083480 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61167459 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.60297703 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59857857 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59479921 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58546505 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57783343 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57660067 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57370684 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.56486710 |
| 111 | RNA degradation_Homo sapiens_hsa03018 | 0.56344714 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56001807 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55532985 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.55052582 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53564275 |
| 116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52583720 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51725609 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51623950 |
| 119 | Purine metabolism_Homo sapiens_hsa00230 | 0.51317928 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48570013 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47456084 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46838136 |
| 123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46508099 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44634208 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44397025 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44228734 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43618309 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.43050822 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42500712 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42469623 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41629369 |
| 132 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41460215 |
| 133 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40310503 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39504995 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39123948 |
| 136 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36793049 |
| 137 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35799451 |

